Biomarker Services for Biopharma

About CND Life Sciences

CND Life Sciences is a pioneering diagnostics company focused on transforming the clinical approach to neurodegenerative diseases through its proprietary skin biopsy technology. Its flagship Syn-One Test, which has performed over 50,000 patient tests, provides objective pathological confirmation of synucleinopathies with high reported accuracy (>95% sensitivity and specificity). The company is commercial, revenue-generating, and expanding its geographic and strategic footprint, including supporting biopharma clinical trials, while navigating a competitive and reimbursement-sensitive market.

Therapeutic Areas